Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

Integrated pharmaceutical group focused on high-end sterile injectables and a global supplier of heparin active ingredient and low molecular weight anticoagulants. Its portfolio also covers oncology, critical care, assisted reproduction and diabetes, with development in biosimilars, monoclonal antibodies and messenger RNA therapies. It reports over eighty ANDA approvals and supply to more than sixty countries.